Rikoon Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Rikoon Group's PFE Position: Q1 2021 in Review
Rikoon Group increased its Pfizer (PFE) stake by 0.11% in Q1 2021, buying an estimated $6.21K and bringing the position to 159,882 shares worth $5.79M. The position accounts for 1.54% of the portfolio, ranked #16.
Rikoon Group first reported a position in PFE in Q3 2016 and has held it in 19 quarters since. The position peaked at $6.1M in Q3 2018. 2,676 funds tracked by Wall St. Rank hold PFE as of Q1 2021.
- Rikoon Group held 159,882 shares of Pfizer worth $5.79M as of Q1 2021.
- Rikoon Group bought 175 Pfizer shares in Q1 2021, an estimated $6.21K.
- Pfizer made up 1.54% of Rikoon Group's portfolio in Q1 2021, its #16 holding.
- Rikoon Group first reported a position in Pfizer in Q3 2016 and has held it in 19 quarters since.
- Rikoon Group's Pfizer position peaked at $6.1M in Q3 2018.
- 2,676 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.
Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.